I F Tannock. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useCarcinoma, Renal Cell/mortalityCarcinoma, Renal Cell/therapyCombined Modality TherapyHumansInterferon alpha-2Interferon-alpha/therapeutic useInterleukin-2/therapeutic useKidney Neoplasms/mortalityKidney Neoplasms/therapyNeoplasm MetastasisNephrectomyPatient SelectionPublication BiasRecombinant ProteinsSurvival Analysis
Substances: See more » Antineoplastic AgentsInterferon alpha-2Interferon-alphaInterleukin-2Recombinant Proteins
Year: 2001 PMID: 11759650 DOI: 10.1056/NEJM200112063452310
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245